Quantcast

Latest biopharmaceutical Stories

2014-07-15 12:29:09

BETHLEHEM, Pa., July 15, 2014 /PRNewswire/ -- Particle Sciences, Inc. has expanded its development capabilities to accommodate the increasing demand for biopharmaceutical formulation and analysis. According to Robert Becker, Vice President Biopharmaceutical Sales and Business Development at Particle Sciences, "Our company has been working with biologics for some time, accumulating significant infrastructure and intellectual property. We regularly work with biopharmaceuticals and...

2014-07-15 08:28:23

MONROVIA, Calif., July 15, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced the appointment of Kurt Gustafson to its board of directors. Mr. Gustafson will also serve as chair of Xencor's audit committee and as a member of the compensation committee. Xencor also announced the promotion of John R....

2014-07-14 12:26:49

CHENGDU,China, July 14, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided updates regarding the Company's Qionglai Facility (QLF). QLF, after the completion of its construction followed by the equipment installation, has conducted a series of procedures and tests that...

2014-07-10 12:30:51

ST. PETERSBURG, Russia, July 10, 2014 /PRNewswire/ -- On July 9 Prime Minister of the Russian Federation Dmitry Medvedev, presented Russia's first national "Industry" award to a biopharmaceutical company BIOCAD [http://biocad.ru/en ]. The Company is developing a unique project called MabNext [http://biocad.ru/en/science ]. Within the scope of MabNext project BIOCAD develops a number of innovative drugs based on monoclonal antibodies for treatment of cancer and autoimmune...

2014-07-09 08:28:06

REDWOOD CITY, Calif., July 9, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus"), announced today the appointment of V. Bryan Lawlis, Jr., Ph.D., former President and CEO of Itero Biopharmaceuticals, to its Board of Directors. "It is a privilege to join this talented Board of Directors, and I am excited about the opportunity to work with the Board and management to make Coherus the leader in the emerging business of biosimilars," Dr. Lawlis stated. "I look forward to working...

2014-07-02 23:06:03

Spread across 210 pages, cell culture market research report by equipment, reagent and applications forecasts the cell culture industry to grow at a CAGR of 10.71% between 2013 and 2018, to reach $24,574 million in 2018. The key drivers for this market are rapid increase in the demand for biopharmaceuticals and increased adoption of single-use technology. Dallas, TX (PRWEB) July 02, 2014 Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth...

2014-07-02 16:25:04

SEATTLE, July 2, 2014 /PRNewswire/ -- CMC Biologics, Inc., a global leader in process development and contract manufacturing, today announced that it has entered in to a Commercial Supply Agreement with Portola Pharmaceuticals, a biopharmaceutical company for the development of andexanet alfa, a potential first-in class Factor Xa inhibitor antidote in Phase 3 ANNEXA(TM) (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of fXA Inhibitors) studies. Andexanet alfa is...

2014-06-25 12:31:16

FREMONT, Calif., June 25, 2014 /PRNewswire/ -- Zosano Pharma Corporation, a privately held pharmaceutical company developing products based on its novel transdermal delivery technology, today announced the election of Troy Wilson, Ph.D., J.D., to its Board of Directors. Dr. Wilson has more than 15 years of experience in the biotechnology industry and a proven track record of building highly successful biopharmaceutical companies. The appointment increases Zosano Pharma's board...

2014-06-19 23:13:54

Transparency Market Research includes new market research report "Biopharmaceutical Outsourcing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its huge collection of research reports. Browse the full report: http://www.transparencymarketresearch.com/biopharmaceutical-outsourcing-market.html Albany, NY (PRWEB) June 19, 2014 Biopharmaceutical market is very competitive and global players occupying majority of market share operate in same...

2014-06-18 12:32:44

--Data indicate ASM-024 DPI safe and generally well-tolerated in asthma-- QUEBEC CITY, Quebec, June 18, 2014 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced top-line results from a combined Phase 1 and 2a trial evaluating its lead compound, ASM-024, in moderate asthma patients. The data comes from Asmacure's recently...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related